Stocks and InvestingStocks and Investing
Tue, January 3, 2023
Fri, December 30, 2022
Thu, December 29, 2022
Wed, December 28, 2022
Tue, December 27, 2022
Fri, December 23, 2022
Thu, December 22, 2022
Wed, December 21, 2022
Tue, December 20, 2022

Joon Lee Maintained (VRNA) at Strong Buy with Increased Target to $28 on, Dec 20th, 2022


Published on 2024-10-28 00:40:11 - WOPRAI, Joon Lee
  Print publication without navigation


Joon Lee of Truist Securities, Maintained "Verona Pharma plc" (VRNA) at Strong Buy with Increased Target from $20 to $28 on, Dec 20th, 2022.

Joon has made no other calls on VRNA in the last 4 months.



There are 2 other peers that have a rating on VRNA. Out of the 2 peers that are also analyzing VRNA, 0 agree with Joon's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joon


  • Raghuram Selvaraju of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $30 on, Monday, August 29th, 2022
  • Yasmeen Rahimi of "Piper Sandler" Initiated at Buy and Held Target at $31 on, Friday, August 26th, 2022